384 related articles for article (PubMed ID: 25142601)
1. Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.
Yen B; Mulder LC; Martinez O; Basler CF
J Virol; 2014 Nov; 88(21):12500-10. PubMed ID: 25142601
[TBL] [Abstract][Full Text] [Related]
2. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
Yen BC; Basler CF
J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
[TBL] [Abstract][Full Text] [Related]
3. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.
Leung LW; Park MS; Martinez O; Valmas C; López CB; Basler CF
Immunol Cell Biol; 2011 Oct; 89(7):792-802. PubMed ID: 21263462
[TBL] [Abstract][Full Text] [Related]
4. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.
Cárdenas WB; Loo YM; Gale M; Hartman AL; Kimberlin CR; Martínez-Sobrido L; Saphire EO; Basler CF
J Virol; 2006 Jun; 80(11):5168-78. PubMed ID: 16698997
[TBL] [Abstract][Full Text] [Related]
5. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.
Edwards MR; Liu G; Mire CE; Sureshchandra S; Luthra P; Yen B; Shabman RS; Leung DW; Messaoudi I; Geisbert TW; Amarasinghe GK; Basler CF
Cell Rep; 2016 Feb; 14(7):1632-1640. PubMed ID: 26876165
[TBL] [Abstract][Full Text] [Related]
6. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.
Luthra P; Ramanan P; Mire CE; Weisend C; Tsuda Y; Yen B; Liu G; Leung DW; Geisbert TW; Ebihara H; Amarasinghe GK; Basler CF
Cell Host Microbe; 2013 Jul; 14(1):74-84. PubMed ID: 23870315
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.
Ramanan P; Edwards MR; Shabman RS; Leung DW; Endlich-Frazier AC; Borek DM; Otwinowski Z; Liu G; Huh J; Basler CF; Amarasinghe GK
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20661-6. PubMed ID: 23185024
[TBL] [Abstract][Full Text] [Related]
8. The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.
Dilley KA; Voorhies AA; Luthra P; Puri V; Stockwell TB; Lorenzi H; Basler CF; Shabman RS
PLoS One; 2017; 12(6):e0178717. PubMed ID: 28636653
[TBL] [Abstract][Full Text] [Related]
9. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.
Ilinykh PA; Lubaki NM; Widen SG; Renn LA; Theisen TC; Rabin RL; Wood TG; Bukreyev A
J Virol; 2015 Aug; 89(15):7567-83. PubMed ID: 25972536
[TBL] [Abstract][Full Text] [Related]
10. The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide.
Jin H; Yan Z; Prabhakar BS; Feng Z; Ma Y; Verpooten D; Ganesh B; He B
J Gen Virol; 2010 Feb; 91(Pt 2):352-61. PubMed ID: 19828757
[TBL] [Abstract][Full Text] [Related]
11. Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
Corona A; Fanunza E; Salata C; Morwitzer MJ; Distinto S; Zinzula L; Sanna C; Frau A; Daino GL; Quartu M; Taglialatela-Scafati O; Rigano D; Reid S; Mirazimi A; Tramontano E
Antiviral Res; 2022 Feb; 198():105251. PubMed ID: 35066016
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.
Leung DW; Prins KC; Borek DM; Farahbakhsh M; Tufariello JM; Ramanan P; Nix JC; Helgeson LA; Otwinowski Z; Honzatko RB; Basler CF; Amarasinghe GK
Nat Struct Mol Biol; 2010 Feb; 17(2):165-72. PubMed ID: 20081868
[TBL] [Abstract][Full Text] [Related]
13. dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35.
Zinzula L; Esposito F; Pala D; Tramontano E
Antiviral Res; 2012 Mar; 93(3):354-63. PubMed ID: 22289166
[TBL] [Abstract][Full Text] [Related]
14. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
15. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
[TBL] [Abstract][Full Text] [Related]
16. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.
Prins KC; Delpeut S; Leung DW; Reynard O; Volchkova VA; Reid SP; Ramanan P; Cárdenas WB; Amarasinghe GK; Volchkov VE; Basler CF
J Virol; 2010 Mar; 84(6):3004-15. PubMed ID: 20071589
[TBL] [Abstract][Full Text] [Related]
17. Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory Responses in Human Dendritic Cells.
Fekete T; Bencze D; Szabo A; Csoma E; Biro T; Bacsi A; Pazmandi K
Front Immunol; 2018; 9():2314. PubMed ID: 30344524
[TBL] [Abstract][Full Text] [Related]
18. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery.
Chang TH; Kubota T; Matsuoka M; Jones S; Bradfute SB; Bray M; Ozato K
PLoS Pathog; 2009 Jun; 5(6):e1000493. PubMed ID: 19557165
[TBL] [Abstract][Full Text] [Related]
19. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1.
Prins KC; Cárdenas WB; Basler CF
J Virol; 2009 Apr; 83(7):3069-77. PubMed ID: 19153231
[TBL] [Abstract][Full Text] [Related]
20. TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA.
Perrot I; Deauvieau F; Massacrier C; Hughes N; Garrone P; Durand I; Demaria O; Viaud N; Gauthier L; Blery M; Bonnefoy-Berard N; Morel Y; Tschopp J; Alexopoulou L; Trinchieri G; Paturel C; Caux C
J Immunol; 2010 Aug; 185(4):2080-8. PubMed ID: 20639488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
